Constellation 3D, Inc. 'C3D' Has Signed With Ricoh Company, Ltd., Japan 'Ricoh' Phase 1 of Strategic Alliance Agreement For WORM Fluorescent Multi-Layer Discs And WORM Drives.Business/High Tech Editors NEW YORK--(BUSINESS WIRE)--Aug. 14, 2000 Constellation 3D, Inc. (OTCBB OTCBB See OTC Bulletin Board (OTCBB). :CFMD) ("C3D A technology developed at the Turing Institute, Glasgow, Scotland for creating 3D models. Using two cameras to obtain stereo images, C3D turns subjects into 3D models in AutoCAD, 3D Studio and virtual reality formats for Internet use. " or the "company") announced today that C3D has signed with Ricoh a Strategic Alliance Agreement. Under the terms of the Agreement, C3D and Ricoh agreed to enter into Phase 1 for prototype development of WORM discs and drives. Constellation 3D, Inc. develops advanced data storage products including the high capacity, multi-layer FMD FMD foot-and-mouth disease. discs and ClearCard(TM). The company has offices in New York, Massachusetts, Florida and California, and laboratories in Israel and Russia. Constellation 3D holds or has made applications for over 75 worldwide patents in the field of optical data storage. More information is available at www.c-3d.net. Statements contained in the news release that are not historical facts are forward-looking statements as that term is defined in the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995. Such forward-looking statements are subject to risks and uncertainties, which may cause actual results to differ materially from expected results. The SEC and NASD NASD See: National Association of Securities Dealers NASD See National Association of Securities Dealers (NASD). have not reviewed and does not accept responsibility for the adequacy or accuracy of this release. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion